Drug
Gabapentin
Gabapentin: highest development phase Post-Market, developed by Pfizer, Zydus. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Pfizer, Zydus
Trials
| Drug | Phase | Indication |
|---|---|---|
| Gabapentin NCT00785772 | Post-Market | Renal Impairment |
| GABAPENTIN | Approved |
Latest
No recent events.
Follow Gabapentin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.